Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 370 shares at $133.95 ($51K) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($51k) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.95 | 15 | $2K | 4.0% |
| 2 | $133.95 | 185 | $25K | 49.0% |
| 3 | $135.69 | 31 | $4K | 8.3% |
| 4 | $140.59 | 117 | $16K | 32.5% |
| 5 | $141.22 | 22 | $3K | 6.1% |
| Total | $136.63 avg | 370 |
| $51K |
| 100% |
| Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |